TaiwanJ Pharmaceuticals Co (ROCO:6549) Operating Cash Flow per Share : NT$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is TaiwanJ Pharmaceuticals Co Operating Cash Flow per Share?

TaiwanJ Pharmaceuticals Co's operating cash flow per share for the six months ended in Dec. 2023 was NT$-0.21. TaiwanJ Pharmaceuticals Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 73.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for TaiwanJ Pharmaceuticals Co's Operating Cash Flow per Share or its related term are showing as below:

ROCO:6549' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -47.7 Med: 31.4 Max: 73.4
Current: 73.4

During the past 11 years, TaiwanJ Pharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 73.40% per year. The lowest was -47.70% per year. And the median was 31.40% per year.

ROCO:6549's 3-Year OCF Growth Rate is ranked better than
97.24% of 1233 companies
in the Biotechnology industry
Industry Median: 3.3 vs ROCO:6549: 73.40

TaiwanJ Pharmaceuticals Co Operating Cash Flow per Share Historical Data

The historical data trend for TaiwanJ Pharmaceuticals Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiwanJ Pharmaceuticals Co Operating Cash Flow per Share Chart

TaiwanJ Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.25

-0.58

-0.13

-0.28

-0.01

TaiwanJ Pharmaceuticals Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.19	-0.17	-0.11	0.20	-0.21

Competitive Comparison of TaiwanJ Pharmaceuticals Co's Operating Cash Flow per Share

For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiwanJ Pharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.

TaiwanJ Pharmaceuticals Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

TaiwanJ Pharmaceuticals Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-0.821	/	75.122
	=	-0.01

TaiwanJ Pharmaceuticals Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-15.648	/	75.122
	=	-0.21

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.01

TaiwanJ Pharmaceuticals Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of TaiwanJ Pharmaceuticals Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiwanJ Pharmaceuticals Co Ltd (ROCO:6549) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rm. D207, Number 2, Sec.2, ShengYi Road, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei, TWN, 30261

Website

http://www.taiwanj.com

TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.

TaiwanJ Pharmaceuticals Co (ROCO:6549) Headlines

No Headlines